New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic

In the last decades, the increasing evidence concerning inflammation mechanisms underlying severe eosinophilic asthma has highlighted new potential therapeutic targets and has paved the way to new selective biologic drugs. Understanding the mechanism of action and the clinical outcomes of a particul...

Descripción completa

Detalles Bibliográficos
Autores principales: Caminati, Marco, Bagnasco, Diego, Vaia, Rachele, Senna, Gianenrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535408/
https://www.ncbi.nlm.nih.gov/pubmed/31190733
http://dx.doi.org/10.2147/BTT.S157183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535408/
https://www.ncbi.nlm.nih.gov/pubmed/31190733
http://dx.doi.org/10.2147/BTT.S157183

Ejemplares similares